Investing in TRx Biosciences

The TRx Leadership Team have exceptional track records in creating value for shareholders and completing transactions. This team is driving TRx through a series of inflection points as the company enters the following growth phases:​

  • Pre-clinical Pipeline Validation​ - Funded and Work On-going
  • Early Clinical Proof-of-Concept​ - Fundraising in H2 2022
  • Patient proof-of-concept​ - Fundraising in H2 2023

TRx is keen to hear from investors interested in joining our progressive journey as TRx delivers on its promise of creating a step-change in the biodistribution of small molecule drugs.